Socid Friendly Socid Friendly
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Marketplace
  • Offers
  • Jobs
  • Forums
  • Jocuri
  • Developers
  • Postari
  • Articles
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Deepak Patle a adăugat un fișier Alte
    2026-03-12 11:12:24
    Clinical Oncology Next Generation Sequencing Market Trends, Precision Oncology Growth, and Forecast 2033
    Clinical Oncology Next Generation Sequencing Industry Insights: Straits Research recently introduced the latest update on the Clinical Oncology Next Generation Sequencing Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous...
    0 Commentarii 0 Distribuiri 1282 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Subhayan Mayra a adăugat un fișier Alte
    2026-04-18 10:04:55
    Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
    According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...
    0 Commentarii 0 Distribuiri 133 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Subhayan Mayra a adăugat un fișier Alte
    2026-04-13 12:28:25
    Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
    According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
    0 Commentarii 0 Distribuiri 648 Views
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 Socid Friendly Romaian
English Indonesia Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Brand Game Online Termeni Confidențialitate Contacteaza-ne Director